 Antibacterial activities vitro vivo pharmacokinetics cefquinome HR new broad-spectrum cephalosporin Cefquinome new injectable aminothiazolyl cephalosporin derivative stable plasmid-encoded beta-lactamases broad antibacterial spectrum Staphylococcus aureus streptococci Pseudomonas aeruginosa members family Enterobacteriaceae Escherichia coli Salmonella Klebsiella Enterobacter Citrobacter Serratia marcescens low concentrations Cefquinome active many strains methicillin-resistant staphylococci enterococci vitro activity gram-negative anaerobes limited high vitro activity cefquinome high vivo efficacy experimental septicemia due different gram-positive gram-negative bacteria pharmacokinetic properties cefquinome mice dogs pigs calves single parenteral administrations high peak levels half-lives areas concentration-time curve dogs mice linear correlations doses dogs urinary recovery dosing